Cargando…
ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway
BACKGROUND: Ligamentum flavum (LF) hypertrophy is the main cause of lumbar spinal canal stenosis (LSCS). Previous studies have shown that LF hypertrophy tissue exhibits abnormal lipid accumulation, but the regulatory mechanism remains unclear. The objective of this study was to explore the function...
Autores principales: | Cao, Yanlin, Li, Jianjun, Qiu, Sujun, Ni, Songjia, Duan, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644428/ https://www.ncbi.nlm.nih.gov/pubmed/37957699 http://dx.doi.org/10.1186/s13062-023-00436-z |
Ejemplares similares
-
Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy
por: Cao, Yanlin, et al.
Publicado: (2021) -
TCF7/SNAI2/miR-4306 feedback loop promotes hypertrophy of ligamentum flavum
por: Duan, Yang, et al.
Publicado: (2022) -
LncRNA XIST facilitates hypertrophy of ligamentum flavum by activating VEGFA-mediated autophagy through sponging miR-302b-3p
por: Cao, Yanlin, et al.
Publicado: (2023) -
Immune cell infiltration and the genes associated with ligamentum flavum hypertrophy: Identification and validation
por: Duan, Yang, et al.
Publicado: (2022) -
Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids
por: Yamada, Tomohiro, et al.
Publicado: (2021)